Neck Cancer

Simplified boron compound may treat brain tumours

Effective and targeted uptake among malignant cells demonstrates the promise of a simplified boron compound for neutron radiation therapy, report researchers at Okayama University and Kinki University.

Sep 16, 2015
popularity21 comments 0

New drug approved for soft-tissue cancer

(HealthDay)—The chemotherapy drug Yondelis (trabectedin) has been approved by the U.S. Food and Drug Administration to treat certain soft-tissue sarcomas (STS) that have spread or can't be treated by surgery.

Oct 23, 2015
popularity10 comments 0

Nomogram predicts death, recurrence with thyroid cancer

(HealthDay)—A new nomogram has excellent discriminatory ability and accuracy in predicting 10-year disease-specific death and recurrence for papillary thyroid carcinoma (PTC), according to a study published online Sept. ...

Oct 01, 2015
popularity5 comments 0

Is your doctor choosing the right IV?

When we doctors sit down with patients in the hospital, discussions regarding diagnosis and prognosis are routine. For patients who need treatments such as antibiotics or chemotherapy beyond the hospital, our conversations ...

Oct 26, 2015
popularity20 comments 0

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

New target could eliminate lurking cancer stem cells

Scientists from Trinity College Dublin have identified a novel target that could help to identify 'cancer stem cells' while they are in their inactive state. The scientists could then jolt these cells into action so that ...

How can I tell if she's lying?

Sarcasm, white lies and teasing can be difficult to identify for those with certain disorders – new video inventory developed at McGill may help

Functional human liver cells grown in the lab

In new research appearing in the prestigious journal Nature Biotechnology, an international research team led by The Hebrew University of Jerusalem describes a new technique for growing human hepatocytes in the laboratory. ...

Combination therapy can prevent cytostatic resistance

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...